Customized Aptamer Selection refers to a tailored process of identifying and developing aptamers—short, single-stranded DNA or RNA molecules—that specifically bind to a target molecule (proteins, small molecules, cells, or pathogens) according to a client’s specific requirements. Unlike standard aptamer screening, it focuses on individualized targets, binding conditions, and functional needs. Key Features: Target Specificity: Aptamers are selected for high affinity and specificity to a particular target. Flexible Design: Can be designed for proteins, peptides, small molecules, ions, or whole cells. Binding Conditions Customization: pH, temperature, ionic strength, or buffer system can be tailored. Functional Application: Aptamers can be developed for diagnostics, therapeutics, biosensors, or research. High-Throughput & Efficiency: Advanced techniques allow rapid screening for optimal aptamers. Typical Workflow: Target Analysis: Understanding target structure and function. Library Preparation: Generate a diverse pool of oligonucleotides. SELEX (Systematic Evolution of Ligands by EXponential enrichment): Iterative selection process to enrich high-affinity aptamers. Binding Affinity Testing: Determine Kd (dissociation constant) and specificity. Sequence Optimization & Modification: Chemical modifications for stability or functionalization. Delivery of Customized Aptamer: Ready for research, diagnostics, or therapeutic use. Common Applications: Diagnostics: Biosensors for disease markers. Therapeutics: Targeted drug delivery. Research Tools: Protein purification or molecular imaging. Environmental Monitoring: Detection of…
What is the Core Service? The service provider uses an iterative, in vitro selection process called SELEX (Systematic Evolution of Ligands by EXponential Enrichment) to screen vast random oligonucleotide libraries (10^14 - 10^15 unique sequences) against your target protein. The output is a set of characterized aptamer sequences that bind to the viral capsid. Standardized Screening Workflow A professional service will manage this entire pipeline: 1. Project Design & Target Preparation: Target Discussion: Defining the specific capsid protein (e.g., HIV-1 CA, HBV core, SARS-CoV-2 N), its form (full-length, domain, assembled capsid/nucleocapsid), and purity. Target Immobilization: The protein is often immobilized on a solid support (beads, plate) to facilitate separation of bound/unbound sequences. Some services offer solution-phase or capillary electrophoresis (CE-SELEX) methods for higher stringency. 2. SELEX Selection Rounds (Cycles 5-15): Incubation: The oligonucleotide library is incubated with the target. Partitioning: Unbound sequences are washed away; bound sequences are retained. Elution: Bound aptamers are eluted (e.g., by heating, denaturing agents). Amplification: Eluted aptamers are amplified by PCR (for DNA) or RT-PCR (for RNA). Purification: The amplified pool is purified for the next selection round. Counter-Selection: To ensure specificity, the pool is often passed through a negative control (e.g., irrelevant protein, cell lysate) to remove non-specific binders. 3. Sequencing & Identification: High-Throughput…
